Phenylalanine kinetics are associated with tardive dyskinesia in men but not in women

Psychopharmacology

Volumn 143, Issue 4, 1999, Pages 347-357

  Richardson, Mary Ann ^a,b   Reilly, Margaret A ^a   Read, Laura L ^a   Flynn, Cheryl J ^a,b   Suckow, Raymond F ^a,c   Maher, Timothy J ^d,e   Sziraki, Istvan ^a,f  

^a NATHAN S KLINE INSTITUTE FOR PSYCHIATRIC RESEARCH   (United States)

^b NEW YORK UNIVERSITY MEDICAL CENTER   (United States)

^c NEW YORK STATE PSYCHIATRIC INSTITUTE   (United States)

^d MASSACHUSETTS COLLEGE OF PHARMACY AND HEALTH SCIENCES   (United States)

^e MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

^f Institute for Drug Research Budapest   (Hungary)

Author keywords

Amine neurotransmitter supersensitivity; Blood brain barrier transport; Gastric emptying; Hepatic clearance; Kinetics; Large neutral amino acid; Movement disorder; Neuroleptic; Neurotransmitter precursors; Neurotransmitter synthesis; Phenylalanine; Plasma absorption; Sex difference; Tardive dyskinesia

Indexed keywords

NEUROLEPTIC AGENT; PHENYLALANINE; TIOTIXENE;

ADULT; AMINO ACID METABOLISM; ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MENTAL DEFICIENCY; NEUROTOXICITY; ORAL DRUG ADMINISTRATION; PATHOPHYSIOLOGY; PREVALENCE; PRIORITY JOURNAL; PROTEIN INTAKE; SCHIZOPHRENIA; SEX DIFFERENCE; TARDIVE DYSKINESIA;

ABSORPTION; ADULT; ANALYSIS OF VARIANCE; BLOOD-BRAIN BARRIER; BRAIN; DYSKINESIA, DRUG-INDUCED; FEMALE; HUMANS; MALE; MENTAL DISORDERS; PHENYLALANINE; SEX FACTORS; TISSUE DISTRIBUTION;

EID: 0032902360     PISSN: 00333158     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002130050958     Document Type: Article

References (81)

1. Acworth IN, Wurtman RJ (1990) Precursor control of catecholamine metabolism. In: Richardson MA (ed) Amino acids in psychiatric disease. American Psychiatric Press, Washington, pp 1-29
2. Berkowitz DM, McCallum RW (1980) Interaction of levodopa and metoclopramide on gastric emptying. Clin Pharmacol Ther 27:414-420
3. Bjerkenstedt L, Edman G, Hagenfeldt L, Sedvall G, Wiesel F-A (1985) Plasma amino acids in relation to cerebrospinal fluid monoamine metabolites in schizophrenic patients and healthy controls. Br J Psychiatry 147:276-282
4. Burt DR, Creese I, Snyder SH (1977) Antischizophrenic drugs: chronic treatment elevates dopamine receptor binding in brain. Science 196:326-328
5. Butler IJ, O'Flynn ME, Seifert WE Jr, Howell RR (1981) Neurotransmitter defects and treatment of disorders of hyperphenylalaninemia. J Pediatr 98:729-733
6. Byerly MJ, DeVane CL (1996) Pharmacokinetics of clozapine and risperidone: a review of recent literature. J Clin Psychopharmacol 16:177-187
7. Caballero B, Wurtman RJ (1988) Control of plasma phenylalanine levels. In: Wurtman RJ, Ritter-Walker E (eds) Dietary phenylalanine and brain function. Birkhauser, Boston, pp 3-12
8. Caballero B, Gleason RE, Wurtman RJ (1991) Plasma amino acid concentrations in healthy elderly men and women. Am J Clin Nut 53:1249-1252
9. Chaudhuri TK, Fink S (1990) Update: pharmaceuticals and gastric emptying. Am J Gastroenterol 85:223-230
10. Chen TS, Doong ML, Chang FY, Lee SD, Wang PS (1995) Effects of sex steroid hormones on gastric emptying and gastrointestinal transit in rats. Am J Physiol 268:G171-G176
11. Clarkston WK, Pantano MM, Morley JE, Horowitz M, Littlefield JM, Burton FR (1997) Evidence for the anorexia of aging: gastrointestinal transit and hunger in healthy elderly vs young adults. Am J Physiol 272:R243-R248
12. Clements JA, Heading RC, Nimmo WS, Prescott LF (1978) Kinetics of acetaminophen absorption and gastric emptying in man. Clin Pharmacol Ther 24:420-431
13. Coskun T, Sevinc A, Tevetoglu I, Alican I, Kurtel H, Yegen BC (1995) Delayed gastric emptying in conscious male rats following chronic estrogen and progesterone treatment. Res Exp Med 195:49-54
14. Curtius H-Ch, Niederwieser A, Visconti M, Leimbacher W, Wegmann H, Blehova B, Ray F, Schaub J, Schmidt H (1981) Serotonin and dopamine synthesis in phenylketonuria. Adv Exp Med Biol 133:277-291
15. Curzon G (1990) Availability of amino acids to the brain and implication for transmitter amine function. In: Richardson MA (ed) Amino acids in psychiatric disease. American Psychiatric Press, Washington, pp 33-48
16. D'Mello DA, McNeil JA (1990) Sex differences in bipolar affective disorder: neuroleptic dosage variance. Comp Psychiatry 31:80-83
17. Daniel PM, Moorhouse SR, Pratt OE (1976) Amino acid precursors of monoamine neurotransmitters and some factors influencing their supply to the brain. Psychol Med 6:277-286
18. Darby JK, Pasta DJ, Dabiri L, Clark L, Mosbacher D (1995) Haloperidol dose and blood level variability: toxicity and interindividual and intraindividual variability in the nonresponder patient in the clinical practice setting. J Clin Psychopharmacol 15:334-340
19. Datz FL, Christian PE, Moore J (1987) Gender-related differences in gastric emptying. J Nucl Med 28:1204-1207
20. Dawbarn D, Long SK, Pycock CJ (1981) Increased central 5-hydroxtryptamine receptor mechanisms in rats after chronic neuroleptic treatment. Br J Pharmacol 73:149-156
21. Ereshefsky L, Lacombe S (1993) Pharmacological profile of risperidone. Can J Psychiatry - Rev Can Psychiatr 38:S80-S88
22. Ereshefsky L, Saklad SR, Watanabe MD, Davis CM, Jann MW (1991) Thiothixene pharmacokinetic interactions: a study of hepatic enzyme inducers, clearance inhibitors, and demographic variables (published erratum appears in J Clin Psychopharmacol (1992) 12:78). J Clin Psychopharmacol 11: 296-301
23. Fibiger HC, Lloyd KG (1984) Neurobiological substrates of tardive dyskinesia: the GABA hypothesis. Trends Neurosci 7: 462-464
24. Filer LJ Jr, Stegink LD (1988) Effect of aspartame on plasma phenylalanine concentration in humans. In: Wurtman RJ, Ritter-Walker E (eds) Dietary phenylalanine and brain function. Birkhauser, Boston, pp 18-40
25. Ganzini L, Heintz RT, Hoffman WF, Casey DE (1991) The prevalence of tardive dyskinesia in neuroleptic-treated diabetics. A controlled study. Arch Gen Psychiatry 48:259-263
26. Ganzini L, Casey DE, Hoffman WF, Heintz RT (1992) Tardive dyskinesia and diabetes mellitus. Psychopharmacol Bull 28:281-286
27. Gryback P, Naslund E, Hellstrom PM, Jacobsson H, Backman L (1996) Gastric emptying of solids in humans: improved evaluation by Kaplan-Meier plots, with special reference to obesity and gender. Eur J Nucl Med 23:1562-1567
28. Gunne LM, Haggstrom JE, Sjoquist B (1984) Association with persistent neuroleptic-induced dyskinesia of regional changes in brain GABA synthesis. Nature 309:347-349
29. Hamilton JA, Yonkers KA (1996) Sex differences in pharmacokinetics of psychotropic medications, part I: physiological basis for effects. In Jensvold MF, Halbreich U, Hamilton JA (eds) Psychopharmacology and women: sex, gender and hormones. American Psychiatric Press, Washington, D.C., pp 11-42
30. Hariharan M, Naga S, VanNoord T (1993) Systematic approach to the development of plasma amino acid analysis by high-performance liquid chromatography with ultraviolet detection with precolumn derivatization using phenyl isothiocyanate. J Chromatogr 621:15-22
31. Haring C, Fleischhacker WW, Schett P, Humpel C, Barnas C, Saria A (1990) Influence of patient-related variables on clozapine plasma levels. Am J Psychiatry 147:1471-1475
32. Harper AE (1984) Phenylalanine metabolism. In: Stegink LD, Filer JJ Jr (eds) Aspartame physiology and biochemistry. Dekker, New York, pp 77-109
33. Harris RZ, Benet LZ, Schwartz JB (1995) Gender effects in pharmacokinetics and pharmacodynamics. Drugs 50:222-239
34. Hawkins RA, Mans AM, Biebuyck JS (1987) Regional transport of phenylalanine and other neutral amino acids across the blood brain barrier. In: Wurtman RJ, Ritter-Walker E (eds) Dietary phenylalanine and brain function. Birkhauser, Boston, pp 63-67
35. Heal DJ, Green AR, Boullin DJ, Graham-Smith DG (1976) Single and repeated administration of neuroleptic drugs to rats; effect on striatal dopamine-sensitive adenylate cyclase and locomotor activity produced by tranylcypromine and L-tryptophan or L-dopa. Psychopharmacology 49:287-300
36. Hermansson G, Sivertsson R (1996) Gender-related differences in gastric emptying rate of solid meals. Digest Dis Sci 41: 1994-1998
37. Hsia DY-Y, Driscoll KW (1956) Detection of the heterozygous carriers of phenylketonuria. Lancet 2:1337
38. Hutson WR, Roehrkasse RL, Wald A (1989) Influence of gender and menopause on gastric emptying and motility. Gastroenterology 96:11-17
39. Javaid JI (1994) Clinical pharmacokinetics of antipsychotics. J Clin Pharmacol 34:286-295
40. Jeste DV, Delisi LE, Zalcman S, Wise CD, Phelps BH, Rosenblatt JE, Potkin SG, Bridge TP, Wyatt RJ (1981) A biochemical study of tardive dyskinesia in young male patients. Psychiatry Res 4:327-331
41. Kane JM, Smith JM (1982) Tardive dyskinesia: prevalence and risk factors 1959 to 1979. Arch Gen Psychiatry 39:473-481
42. Kao CH, Lai TL, Wang SJ, Chen GH, Yeh SH (1994) Influence of age on gastric emptying in healthy Chinese. Clin Nucl Med 19:401-404
43. Kaufmann CA, Jeste DV, Shelton RC, Linnoila M, Kafka MS, Wyatt RJ (1986) Noradrenergic and neuroradiological abnormalities in tardive dyskinesia. Biol Psychiatry 21:799-812
44. Knight LC, Parkman HP, Brown KL, Miller MA, Trate DM, Maurer AH, Fisher RS (1997) Delayed gastric emptying and decreased antral contractility in normal premenopausal women compared with men. Am J Gastroenterol 92:968-975
45. Lehnert H, Wurtman RJ (1993) Amino acid control of neurotransmitter synthesis and release: physiological and clinical implications. Psychother Psychosom 60:18-32
46. Lieberman J, Kane JM, Woerner M, Weinhold P, Basavaraju N, Kurucz J, Bergmann K (1984) Prevalence of tardive dyskinesia in elderly samples. Psychopharmacol Bull 20:382-386
47. Lin SK, Chang WH, Chung MC, Lam YW, Jann MW (1994) Disposition of clozapine and desmethylclozapine in schizophrenic patients. J Clin Pharmacol 34:318-324
48. Lu R-B, Ko H-C, Lin W-L, Lin YT, Ho S-L (1989) CSF neurochemical study of tardive dyskinesia. Biol Psychiatry 25: 717-724
49. Macdonald I, Keyser A, Pacy D (1978) Some effects, in man, of varying the load of glucose, sucrose, fructose, or sorbitol on various metabolites in blood. Am J Clin Nutr 31:1305-1311
50. Maher T (1990) Effects of phenylalanine on the synthesis, release, and function of catecholaminergic systems. In: Richardson MA (ed) Amino acids in psychiatric disease. American Psychiatric Press, Washington, pp 131-142
51. Moore DC, Glazer WM, Bowers MB, Jr., Heninger GR (1983) Tardive dyskinesia and plasma homovanillic acid. Biol Psychiatry 18:1393-1402
52. Muller P, Seeman P (1977) Brain neurotransmitter receptors after long-term haloperidol: dopamine, acetylcholine, serotonin, anoradrenergic and naloxone receptors. Life Sci 21:1751-1758
53. Nadler HL, Hsia DY (1961) Enpinephrine metabolism in phenylketonuria. Proc Soc Exp Biol med 107: 721-723
54. Nimmo WS (1976) Drugs, diseases and altered gastric emptying. Clin Pharmacokinet 1:189-203
55. Pan RM, Mauron C, Glaeser B, Wurtman RJ (1982) Effect of various oral glucose doses on plasma neutral amino acid levels. Metab Clin Exp 31:937-943
56. Pardridge WM, Choi TB (1986) Neutral amino acid transport at the human blood-brain barrier. Fed Proc 45:2073-2078
57. Pare CMB, Sandler M, Stacey RS (1957) 5-Hydroxytryptamine deficiency in phenylketonuria. Lancet 1: 551-553
58. Potkin SG, Cannon-Spoor HE, Delisi LE, Neckers LM, Wyatt RJ (1983) Plasma phenylalanine, tyrosine, and tryptophan in schizophrenia. Arch Gen Psychiatry 40:749-752
59. Proud VK, Hsia YE, Wolf B (1989) Disorders of amino acid metabolism. In: Siegel GJ, Agranoff B, Albers RW, Molinoff P (eds) Basic neurochemistry: molecular, cellular, and medical aspects, 4th edn. Raven Press, New York, pp 733-763
60. Rampini S, Anders PW, Curtius HC, Marthaler T (1969) Detection of heterozygotes for phenylketonuria by column chromatography and discriminatory analysis. Pediatr Res 3:287-297
61. Rao ML, Gross G, Strebel B, Braunig P, Huber G, Klosterkotter J (1990) Serum amino acids, central monoamines, and hormones in drug-naive, drug-free, and neuroleptic-treated schizophrenic patients and healthy subjects. Psychiatry Res 34: 243-257
62. Richardson MA, Craig TJ (1982) The coexistence of parkinsonism-like symptoms and tardive dyskinesia. Am J Psychiatry 139: 341-343
63. Richardson MA, Haugland G, Pass R, Craig TJ (1986) The prevalence of tardive dyskinesia in a mentally retarded population. Psychopharmacol Bull 22:243-249
64. Richardson MA, Casey DE, Lin S (1989a) Tardive dyskinesia: resolving, persisting, new cases - demographics and treatment. Biol Psychiatry 25:161A
65. Richardson MA, Suckow R, Whittaker R, Boggiano W, Sziraki I, Kushner H, Perumal A (1989b) The plasma phenylalanine/large neutral amino acid ratio: a risk factor for tardive dyskinesia. Psychopharmacol Bull 25:47-51
66. Rudman D, Abbasi AA, Chaudry F, Mattson DE (1991) Delayed plasma clearance of phenylalanine and tyrosine in elderly men. J Am Geriat Soc 39:33-38
67. Salokangas RK (1995) Gender and the use of neuroleptics in schizophrenia. Further testing of the oestrogen hypothesis. Schizophr Res 16:7-16
68. Salokangas RK, Saarijarvi S, Taiminen T, Lehto H, Niemi H, Ahola V, Syvalahti E (1997) Effect of smoking on neuroleptics in schizophrenia. Schizophr Res 23:55-60
69. Sandyk R, Consroe PF, Iacono RP (1986) L-Tryptophan in drug-induced movement disorders with insomnia. N Engl J Med 314:1257
70. Sarwar G, Botting HG, Collins M (1991) A comparison of fasting serum amino acid profiles of young and elderly subjects. J Am Coll Nutr 10:668-674
71. Scriver CR, Rosenberg LE (1973) Phenylalanine. In: Schaffer AL (ed) Amino acid metabolism and its disorders. Saunders, Philadelphia, pp 290-337
72. Seeman P (1988) Tardive dyskinesia, dopamine receptors, and neuroleptic damage to cell membranes. J Clin Psychopharmacol 8:3S-9S
73. Simpson GM, Yadalam KG, Levinson DF, Stephanos MJ, Lo ES, Cooper TB (1990) Single-dose pharmacokinetics of fluphenazine after fluphenazine decanoate administration. J Clin Psychopharmacol 10: 417-421
74. Smith JM, Oswald WT, Kucharski LT, Waterman LJ (1978) Tardive dyskinesia: age and sex differences in hospitalized schizophrenics. Psychopharmacology 58:207-211
75. Snoeck E, Van Peer A, Sack M, Horton M, Mannens G, Woestenborghs R, Meibach R, Heykants J (1995) Influence of age, renal and liver impairment on the pharmacokinetics of risperidone in man. Psychopharmacology 122:223-229
76. Stegink LD (1984) Aspartame metabolism in humans: acute dosing studies. In: Stegink LD, Filer LJ Jr (eds) Aspartame physiology and biochemistry. Dekker, New York, pp 509-553
77. Tamminga CA, Crayton JW, Chase TN (1979) Improvement in tardive dyskinesia after muscimol therapy. Arch Gen Psychiatry 36:595-598
78. Thaker GK, Tamminga CA, Alphs LD, Lafferman J, Ferraro TN, Hare TA (1987) Brain gamma-aminobutyric acid abnormality in tardive dyskinesia. Reduction in cerebrospinal fluid GABA levels and therapeutic response to GABA agonist treatment. Arch Gen Psychiatry 44:522-529
79. Yassa R, Jeste DV (1992) Gender differences in tardive dyskinesia: a critical review of the literature. Schizophr Bull 18:701-715
80. Yassa R, Nair NPV, Iskandar H, Schwartz G (1990) Factors in the development of severe forms of tardive dyskinesia. Am J Psychiatry 147:1156-1162
81. Yonkers KA, Kando JC, Cole JO, Blumenthal S (1992) Gender differences in pharmacokinetics and pharmacodynamics of psychotropic medication. Am J Psychiatry 149:587-595